DexTech Medical is a biotechnology research company. Today specialisation is in the area of urologic oncology, where common diseases include prostate cancer. A significant part of the research is carried out in collaboration with international players, research institutes and universities. The company was established in 2004 and is based in Uppsala.

Quotes for DexTech Medical AB

Created with Highstock 6.0.7CloseTraded Volume13. jan20. jan27. jan10. feb17. feb24. feb3. mar10. mar17. mar24. mar31. mar3.33.63.94.24.504T8T12T16T

Right Now

+/-
-0.16
%
−4,12%
Latest
3.72
High
3.94
Low
3.72
Volume
3 740
Turnover (SEK)
14 236
Market Value (MSEK)
68,8
Time (Latest trade)

Board

CEO

  • Anders Holmberg

Chairperson of the Board

  • Andreas Segerros

Board

  • Per-Olov Asplund
  • Peter Benson
  • Rolf Eriksson
  • Svante Wadman
  • Articles of association

    • News

    Show More

    News agencies

    Show More

    Analysis

    Videos

    Hearing med DexTech

    Hearing med DexTech

    Hearing med DexTech

    Hearing med DexTech

    Hearing med DexTech

    Largest Owners

    Name Capital % Votes % Date
    Svante Wadman 21,45 21,45 2024-12-23
    Anders Holmberg 8,51 8,51 2024-12-23
    Sten Nilsson 7,75 7,75 2024-12-23
    Donald Ericsson Fastigheter VI AB 6,08 6,08 2024-12-23
    Gösta Lundgren 5,96 5,96 2024-12-23
    Hans Andersson med familj 5,60 5,60 2023-02-20
    Nordnet Pensionsförsäkring 3,53 3,53 2024-12-23
    Avanza Pension 3,48 3,48 2024-12-23
    Mats Ragnarsson Holmberg 2,32 2,32 2024-12-23
    Peter Kanekrans 2,07 2,07 2024-12-23
    ** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

    Insider trading

    NameTransaction DateTypeInstrumentAmountPriceValueCurrency
    Anders Holmberg2023-02-16Buy TransactionDexTech Medical 1 6855,18 593,5SEK
    Anders Holmberg2023-02-16Buy TransactionDexTech Medical 2065,061 042,4SEK
    Svante Wadman2019-06-28en-USDexTech Medical 44 552602 673 120,0SEK
    Gösta Lundgren2019-06-26en-USDexTech Medical 3456020 700,0SEK
    Gösta Lundgren2019-06-26en-USDexTech Medical 1 6226097 320,0SEK
    Per Asplund2019-06-19Buy TransactionDexTech Medical 6006036 000,0SEK
    Sten Folke Nilsson2016-10-26Sell TransactionAktier- 100 0002600000−260 000 000 000,0SEK
    C,R, Services AB I2016-10-13en-USDEX BTA 1 2162631 616,0SEK
    Gösta Lundgren2016-10-13en-USDEX BTA 42 758261 111 708,0SEK
    Gösta Lundgren2016-10-11Buy TransactionDEX TR 1 026 1920,0549 257,2SEK
    Rolf Eriksson2016-10-13Buy Transaction009155450 3 7002696 200,0SEK
    Svante Karl-Johan Wadman2016-10-12en-USAktier Dextech Medical AB 156 825264 077 450,0SEK
    Gösta Lundgren2016-10-11Sell TransactionDEX TR- 1 026 1920,02−23 602,4SEK
    Sten Folke Nilsson2016-10-10en-USDextech Medical AB- 1 513 5490−0,0SEK
    Sten Folke Nilsson2016-10-10en-USDextech Medical AB 18 40819942367 092 336,0SEK
    Anders Holmberg2016-10-04en-USaktier 19 65026510 900,0SEK
    Anders Holmberg2016-10-04en-USteckningsrätter- 1 071 9770−0,0SEK
    *Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

    Key Numbers

    2024-12-312024-09-302024-06-302024-06-302024-03-312023-12-312023-09-30
    Number of months that the report spans Q2 3 MonthsQ1 3 Months2024Q4 3 MonthsQ3 3 MonthsQ2 3 MonthsQ1 3 Months
    Total revenue MSEK0.000.000.000.000.000.000.00
    Earnings before interest and tax MSEK-1.11-1.29-5.55-1.60-1.48-1.38-1.09
    Profit before tax MSEK-0.96-1.14-4.71-1.29-1.42-1.08-0.92
    Net profit MSEK-0.96-1.14-4.71-1.29-1.42-1.08-0.92
    Earnings per share SEK-0.00-0.00-0.00-0.00-0.00-0.00-0.00
    Dividend per share SEK0.00
    Equity MSEK27.5128.4729.6129.6130.9032.3233.40
    Fixed assets MSEK0.000.000.000.000.000.000.00
    Intangible assets MSEK11.0310.5710.9110.9110.4810.1810.12
    Current assets MSEK16.6918.5819.6819.6821.5522.6224.02
    Total asset MSEK27.7229.1630.5930.5932.0332.8034.14
    Long term liabilities MSEK0.000.000.000.000.000.000.00
    Current liabilities MSEK0.210.690.980.981.130.480.74
    Number of shares SEK18.4918.4918.4918.4918.4918.4918.49
    *Compiled data from Millistream

    Upcoming reports

    • 2025-04-29 Delårsrapport 2025-Q3

    • 2025-08-30 Bokslutskommuniké 2025

    Annual reports, prospectus etc.